6 females (60%). Group B also consisted of 10 patients (10) and a gender distribution of 6 males (60%) and 4 females(40%). These data were presented in Figure 5 and Table 2.
4.3. Duration of Symptoms. The mean duration of symptoms (in weeks) for Group A was 9.1 0.88 and for Group B was 8.8 0.91 weeks. There is no significant difference between the duration of symptom of the two groups at 5% level of significance as shown in Figure 6 and Table 3.